mCRPC patients with PSA fluctuations under radioligand therapy have comparable survival benefits relative to patients with sustained PSA decrease
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
In: European Journal of Nuclear Medicine and Molecular Imaging (2022) 49:13, 4727-4735. DOI: 10.1007/s00259-022-05910-w
- Event
-
Veröffentlichung
- (where)
-
Würzburg
- (who)
-
Universität Würzburg
- (when)
-
2024
- Creator
-
Hartrampf, Philipp Emanuel
Bundschuh, Ralph A.
Weinzierl, Franz-Xaver
Serfling, Sebastian
Kosmala, Aleksander
Seitz, Anna Katharina
Kübler, Hubert
Buck, Andreas K.
Essler, Markus
Wolf, Herta
- DOI
-
10.1007/s00259-022-05910-w
- URN
-
urn:nbn:de:bvb:20-opus-324562
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:03 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Hartrampf, Philipp Emanuel
- Bundschuh, Ralph A.
- Weinzierl, Franz-Xaver
- Serfling, Sebastian
- Kosmala, Aleksander
- Seitz, Anna Katharina
- Kübler, Hubert
- Buck, Andreas K.
- Essler, Markus
- Wolf, Herta
- Universität Würzburg
Time of origin
- 2024
Other Objects (12)
mCRPC patients with PSA fluctuations under radioligand therapy have comparable survival benefits relative to patients with sustained PSA decrease
PSA
PSA
Nadir PSA level and time to nadir PSA are prognostic factors in patients with metastatic prostate cancer
Die prognostische Aussagekraft des freien prozentualen PSA (f-PSA, t-PSA)
Zonal adjusted PSA density improves prostate cancer detection rates compared with PSA in Taiwanese males with PSA < 20 ng/ml
Výcvik psa
Výcvik psa
-STORe - PSA
Výchova psa
ΨΑ
Die PSA-Density als Parameter zur Verbesserung der Prostatakarzinomdiagnostik : Vergleich der PSA-Density mit prozentual freiem PSA und Gesamt-PSA
mCRPC patients with PSA fluctuations under radioligand therapy have comparable survival benefits relative to patients with sustained PSA decrease
PSA
PSA
Nadir PSA level and time to nadir PSA are prognostic factors in patients with metastatic prostate cancer
Die prognostische Aussagekraft des freien prozentualen PSA (f-PSA, t-PSA)
Zonal adjusted PSA density improves prostate cancer detection rates compared with PSA in Taiwanese males with PSA < 20 ng/ml
Výcvik psa
Výcvik psa
-STORe - PSA
Výchova psa
ΨΑ
Die PSA-Density als Parameter zur Verbesserung der Prostatakarzinomdiagnostik : Vergleich der PSA-Density mit prozentual freiem PSA und Gesamt-PSA
mCRPC patients with PSA fluctuations under radioligand therapy have comparable survival benefits relative to patients with sustained PSA decrease
PSA
PSA
Nadir PSA level and time to nadir PSA are prognostic factors in patients with metastatic prostate cancer
Die prognostische Aussagekraft des freien prozentualen PSA (f-PSA, t-PSA)
Zonal adjusted PSA density improves prostate cancer detection rates compared with PSA in Taiwanese males with PSA < 20 ng/ml
Výcvik psa
Výcvik psa
-STORe - PSA
Výchova psa
ΨΑ